MEDICALLY REVIEWED

The FDA has Granted Full Approval to Pembrolizumab for the Treatment of Unresectable Or Msi-H Or Dmmr Solid Tumour

Last medically reviewed on 8 May 2023

This marks the first-ever FDA approval for immunotherapy based on a predictive biomarker, regardless of solid tumour type.

Sign Up or Log In as a healthcare professional to read the full article.

Tony Zhang

A recent Bachelor of Biomedicine graduate and a current Doctor of Medicine student in the University of Melbourne, Tony is motivated to strive for his best in study, work and volunteering. He is a firm believer in the power of simple language to spread healthcare knowledge and promote public health awareness among Asian population.

Share via

Also worth reading

Liver: Its Functions And Conditions Affecting It

July 26, 2021

If you were to name an important solid organ in your digestive system, it would

Understanding Health Insurance: Coverage Options and Key Considerations for Singaporeans

April 19, 2023

Explore health insurance options in Singapore and considerations for choosing a plan to cover healthcare

Keto Diet and Cancer: Beneficial or Concerning?

June 21, 2023

The keto diet’s impact on cancer prevention and treatment is debated. We explore evidence regarding

Selangor International Expo (MEDIC) 2023: Advancing Healthcare Innovation and Collaboration

Selangor International Expo (MEDIC) 2023 brings together healthcare professionals to advance the industry through collaboration and innovation at exhibitions, conferences, workshops and startup showcases. The expo provides a platform to drive transformation in healthcare.

June 21, 2023

Weekly Asian Medical News Bulletin – 11 August 2023

Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This week’s bulletin will cover obesity,

August 11, 2023

Asia to Face Obesity Epidemic by 2035

The World Obesity Federation (WOF) has issued a warning that by 2035, Asia is likely to face a severe obesity epidemic, with over 50% of

March 7, 2023

PUBLIC PORTAL

MEDICALLY REVIEWED

The FDA has Granted Full Approval to Pembrolizumab for the Treatment of Unresectable Or Msi-H Or Dmmr Solid Tumour

Tony Zhang

Share via

Also worth reading

Liver: Its Functions And Conditions Affecting It

Understanding Health Insurance: Coverage Options and Key Considerations for Singaporeans

Keto Diet and Cancer: Beneficial or Concerning?

People also read:

Selangor International Expo (MEDIC) 2023: Advancing Healthcare Innovation and Collaboration

Weekly Asian Medical News Bulletin – 11 August 2023

Asia to Face Obesity Epidemic by 2035

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

My Account

Privacy Policy

FOLLOW MCA

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

PUBLIC PORTAL

MEDICALLY REVIEWED

The FDA has Granted Full Approval to Pembrolizumab for the Treatment of Unresectable Or Msi-H Or Dmmr Solid Tumour

Tony Zhang

Share via

Also worth reading

People also read:

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved. The contents on Medical Channel Asia are for general educational purposes only. It is not intended to be a substitute for professional medical advice, treatment, or diagnosis. See additional information.

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.